Literature DB >> 9271034

Clinical applications of C-reactive protein in pediatrics.

D L Jaye1, K B Waites.   

Abstract

The body of literature concerning studies of the applications of CRP measurement in the pediatric population continues to grow. Based on current data serial CRP measurements appear to be most useful for monitoring patient response to therapy after the primary diagnosis of invasive infectious or inflammatory diseases, for monitoring patients after major surgical procedures and those with serious burns. Monitoring CRP over time may be used to assess for recrudescent disease, a secondary process or ineffective therapy. In addition CRP appears to be suited to most applications for which the ESR is used but offers many advantages. At present there are no objective outcome-based clinical trial data to justify using CRP values alone, whether elevated or normal, as a basis for management decisions regarding instituting or withholding antimicrobial therapy, or its early discontinuance for patients suspected of having neonatal sepsis, meningitis, bacteremia or pneumonia, regardless of immune status. In addition, because of significant inconsistencies among studies for which CRP has been applied to differential diagnosis of bacterial vs. viral diseases, including meningitis, acute otitis media and lower respiratory tract infection, we cannot recommend it for this purpose. Data do not support a role for CRP in differential diagnosis of acute appendicitis or for localizing urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271034     DOI: 10.1097/00006454-199708000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  65 in total

Review 1.  Infections in neurosurgery: using laboratory data to plan optimal treatment strategies.

Authors:  Erwin M Brown
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Rest energy expenditure is decreased during the acute as compared to the recovery phase of sepsis in newborns.

Authors:  Rubens Feferbaum; Cláudio Leone; Arnaldo Af Siqueira; Vitor E Valenti; Paulo R Gallo; Alberto Oa Reis; Ary C Lopes; Viviane G Nascimento; Adriana G de Oliveira; Tatiana Dias de Carvalho; Rubens Wajnsztejn; Claudia de Castro Selestrin; Luiz Carlos de Abreu
Journal:  Nutr Metab (Lond)       Date:  2010-07-23       Impact factor: 4.169

3.  Role of Procalcitonin in Evaluation of the Severity of Acute Cholecystitis.

Authors:  Yucel Yuzbasioglu; Hikmet Duymaz; Ceren Sen Tanrikulu; Huseyin Cahit Halhalli; Mirac Ozturk Koc; Meral Tandoğan; Figen Coskun
Journal:  Eurasian J Med       Date:  2016-10

Review 4.  Procalcitonin in pediatrics: overview and challenge.

Authors:  C Chiesa; L Pacifico; G Mancuso; A Panero
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

5.  Evidence of a causal link between health outcomes, insurance coverage, and a policy to expand access: experimental data from children in the Philippines.

Authors:  Stella A Quimbo; John W Peabody; Riti Shimkhada; Jhiedon Florentino; Orville Solon
Journal:  Health Econ       Date:  2011-05       Impact factor: 3.046

6.  Conservative/surgical treatment predictors of maternal hydronephrosis: results of a single-center retrospective non-randomized non-controlled observational study.

Authors:  Hakan Ercil; Burak Arslan; Ferhat Ortoglu; Ergun Alma; Umut Unal; Mehmet Eflatun Deniz; Aykut Bugra Senturk; Zafer Gokhan Gurbuz
Journal:  Int Urol Nephrol       Date:  2017-05-17       Impact factor: 2.370

7.  Host lung gene expression patterns predict infectious etiology in a mouse model of pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Jiexin Zhang; Derek T Larson; Cesar D García; Sylvia Martinez-Pro; Kevin R Coombes; Burton F Dickey
Journal:  Respir Res       Date:  2010-07-23

8.  Amoxicillin-induced aseptic meningoencephalitis.

Authors:  Radi Shahien; Vetaly Vieksler; Abdalla Bowirrat
Journal:  Int J Gen Med       Date:  2010-07-21

Review 9.  Acute otitis media with spontaneous tympanic membrane perforation.

Authors:  N Principi; P Marchisio; C Rosazza; C S Sciarrabba; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

10.  The health and cost impact of care delay and the experimental impact of insurance on reducing delays.

Authors:  Aleli D Kraft; Stella A Quimbo; Orville Solon; Riti Shimkhada; Jhiedon Florentino; John W Peabody
Journal:  J Pediatr       Date:  2009-04-25       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.